Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference
November 21, 2022 16:05 ET
|
Third Harmonic Bio
CAMBRIDGE, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for allergy and...
Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 09, 2022 16:15 ET
|
Third Harmonic Bio
Successfully Completed Upsized Initial Public Offering Providing Funding Through 2025 Patient Dosing Underway in Phase 1b Chronic Inducible Urticaria Clinical Trial CAMBRIDGE, Mass., Nov. 09, 2022 ...
Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 19, 2022 16:10 ET
|
Third Harmonic Bio
CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for...
Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering
September 14, 2022 19:33 ET
|
Third Harmonic Bio
CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for...
Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directors
August 09, 2022 08:30 ET
|
Third Harmonic Bio
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment...
Julie Person Joins Third Harmonic Bio as Chief Administrative Officer
June 28, 2022 14:14 ET
|
Third Harmonic Bio
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of...